Literature DB >> 12211123

Personality traits and socio-epidemiological status of hospitalised elderly benzodiazepine users.

Mirko Petrovic1, Andre Vandierendonck, Ann Mariman, Georges van Maele, Marcel Afschrift, Dirk Pevernagie.   

Abstract

OBJECTIVE: to define personality traits and socio-epidemiological status of hospitalised elderly chronic benzodiazepine (BZD) users.
METHODS: this case controlled study assessed psychological characteristics (using the Millon Clinical Multiaxial Inventory-MCMI-I) and socio-epidemiological status (sex, age, education, marital status and housing) in 40 hospitalised geriatric patients taking BZDs for at least 3 months and 40 non-users, excluding dementia.
RESULTS: comparisons between groups: Compulsive personality pattern was more pronounced in the control group (p = 0.008). Severe personality pathology: a predisposition to borderline disorder was stronger among the BZD-users (p = 0.001). Clinical syndromes: anxiety, dysthymic disorder (p < 0.001) and tendency to alcohol dependence (p = 0.020) prevailed in the BZD-users. No severe syndromes were found. Widowed persons were more prevalent between the BZD-users (p = 0.03). All significant differences resulted from disparities between females. Predictors of BZD-use and clustering of traits: Dysthymic disorder was predictive of BZD-use (odds ratio (OR) 6.3 [95% confidence intervals (CI) 2.2-18.2]). It was strongly correlated with anxiety (r(s) = 0.93) and somatoform disorder (r(s) = 0.71). Dysthymic disorder and alcohol dependence predicted BZD-use in women (OR 15.3 [CI: 2.4-95.7] and OR 9.1 [CI: 1.2-64.9], respectively). There were no specific predictors in men.
CONCLUSIONS: chronic elderly BZD-users are typically widowed females with dysthymic disorder, anxiety, predisposition to alcohol dependence and borderline disorder. Before prescribing BZDs, it is important to recognize the nature of the elderly population at risk for BZD-use and to consider a broader-ranging therapeutic management of the predisposing personality traits. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211123     DOI: 10.1002/gps.677

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  7 in total

1.  Personality and health in middle age as predictors for well-being and health in old age.

Authors:  Pasqualina Perrig-Chiello; Susanne M Jaeggi; Martin Buschkuehl; Hannes B Stähelin; Walter J Perrig
Journal:  Eur J Ageing       Date:  2008-12-09

2.  A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.

Authors:  Daniela C Moga; Heidi Taipale; Anna-Maija Tolppanen; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen; Qishan Wu; Gregory A Jicha; Danijela Gnjidic
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

Review 3.  A Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults.

Authors:  Rachel D Maree; Zachary A Marcum; Ester Saghafi; Debra K Weiner; Jordan F Karp
Journal:  Am J Geriatr Psychiatry       Date:  2016-06-07       Impact factor: 4.105

4.  Medication dependence and anxiety.

Authors:  Lisa L von Moltke; David J Greenblatt
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

5.  Withdrawal-induced delirium associated with a benzodiazepine switch: a case report.

Authors:  Herbert Bosshart
Journal:  J Med Case Rep       Date:  2011-05-26

Review 6.  Clinical interventions for late-life anxious depression.

Authors:  Gretchen J Diefenbach; John Goethe
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

7.  Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies.

Authors:  Philippe Voyer; David Cohen; Sylvie Lauzon; Johanne Collin
Journal:  BMC Nurs       Date:  2004-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.